IDbyDNA is a metagenomics technology company setting the standard for detection, identification and interpretation of microorganisms and their role in human health.
IDbyDNA develops the technologies that will enable nucleic acid based identification of any life form on Earth.
IDbyDNA was founded in 2014 by Guochun Liao, alongside with Robert Schlaberg and Mark Yandell. The company is headquartered in San Francisco, California, with an office in Salt Lake City, Utah.
IDbyDNA has developed a transformative metagenomics technology to simultaneously profile tens of thousands of microorganisms and pathogens in any sample. The company's turn-key Explify® platform easily integrates into medical laboratories to deliver actionable information to healthcare providers.
The Explify platform utilizes next-generation sequencing (NGS)-based metagenomics, enabling more comprehensive pathogen detection and profiling than traditional PCR testing. Metagenomics is more resilient to quickly evolving pathogens, such as many viruses, and ensures that the test can be quickly adapted to emerging pathogens.
IDbyDNA is backed by Artis Ventures, Genesys Capital, ARUP Laboratories, Abstract Ventures and others. The company raised $20M in a Series B financing on Jan 29, 2020. This brings IDbyDNA's total funding to $29M to date.